What are the effects of an overdose of rosuvastatin (a statin medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Rosuvastatin overdose is a medical emergency that requires immediate attention, and treatment should focus on supportive care, including monitoring liver and kidney function, checking creatine kinase levels, and providing intravenous fluids. The effects of an overdose of rosuvastatin can be severe and may include muscle pain, weakness, kidney problems, and liver dysfunction 1. There is no specific antidote for rosuvastatin overdose, and hemodialysis is not effective in removing the drug from the body due to its high protein binding 1.

Key considerations in managing rosuvastatin overdose include:

  • Monitoring liver and kidney function to assess for potential damage
  • Checking creatine kinase levels to evaluate muscle damage
  • Providing intravenous fluids to support hydration and renal output
  • Considering the use of activated charcoal if the overdose was recent to reduce absorption
  • Being aware of potential drug-drug interactions, especially with immunosuppressants, which can increase the risk of muscle-related toxicity 1

It is crucial to prioritize prevention by taking rosuvastatin exactly as prescribed, keeping it out of reach of children, and never taking extra doses to "catch up" if a dose is missed. In the event of an overdose, calling poison control (1-800-222-1222) or going to the emergency room right away is essential. The most recent guidelines, such as those from the American Heart Association and American College of Cardiology 1, emphasize the importance of careful management and monitoring in patients taking statins, including rosuvastatin, to minimize the risk of adverse effects.

From the FDA Drug Label

In case of an overdose, get medical help or contact a live Poison Center expert right away at 1-800-222-1222. The effects of an overdose of rosuvastatin are not explicitly described in the drug label. Key points:

  • The label advises to get medical help or contact a Poison Center expert in case of an overdose.
  • It does not provide information on the specific effects of an overdose. 2

From the Research

Effects of Rosuvastatin Overdose

The effects of an overdose of rosuvastatin, a statin medication, can be severe and include:

  • Rhabdomyolysis, a condition characterized by the breakdown of muscle tissue, leading to acute kidney injury and other complications 3, 4, 5
  • Elevated serum creatine kinase concentration, indicating muscle damage 3, 4, 5
  • Acute kidney injury, which may require haemodialysis 3, 4
  • Myalgia, or muscle pain, and weakness 4, 5
  • Increased risk of renal toxicity, particularly in patients with pre-existing kidney disease 6

Risk Factors for Rosuvastatin-Induced Rhabdomyolysis

Certain factors can increase the risk of developing rhabdomyolysis due to rosuvastatin overdose, including:

  • High doses of rosuvastatin, particularly above 40 mg/day 4, 7
  • Medication errors, such as taking multiple rosuvastatin-containing preparations simultaneously 4
  • Pre-existing kidney disease, particularly stage IV chronic kidney disease 6
  • Certain genetic factors, such as the CYP2C9*1/*3 genotype 4
  • Concomitant use of other medications, such as warfarin 4

Clinical Presentation and Management

Patients presenting with rosuvastatin-induced rhabdomyolysis may exhibit symptoms such as:

  • Progressive asthenia and diffuse myalgia 4
  • Generalized muscle pain, weakness, and easy fatigability 5
  • Dark urine, indicating myoglobinuria 5 Management of rosuvastatin-induced rhabdomyolysis typically involves:
  • Immediate withdrawal of rosuvastatin 3, 4, 5
  • Intravenous fluid administration and monitoring of serum electrolytes 5
  • Haemodialysis, if necessary, to manage acute kidney injury 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rosuvastatin-induced rhabdomyolysis due to medication errors.

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2020

Research

Drug safety evaluation of rosuvastatin.

Expert opinion on drug safety, 2011

Research

Rosuvastatin: an independent analysis of risks and benefits.

MedGenMed : Medscape general medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.